key: cord-0742967-akzlp041 authors: Papadopoulos, N. G.; Mathioudakis, A. G.; Custovic, A.; Deschildre, A.; Phipatanakul, W.; Wong, G.; Xepapadaki, P.; Abou-Taam, R.; Agache, I.; Castro-Rodriguez, J. A.; Chen, Z.; Cros, P.; Dubus, J.-C.; El-Sayed, Z. A.; El-Owaidy, R.; Feleszko, W.; Fierro, V.; Fiocchi, A.; Garcia-Marcos, L.; Goh, A.; Hossny, E. M.; Huerta Villalobos, Y. R.; Jartti, T.; Le Roux, P.; Levina, J.; Lopez Garcia, A. I.; Mazon Ramos, A.; Morais Almeida, M.; Murray, C.; Nagaraju, K.; Nagaraju, M. K.; Navarrete Rodriguez, E. M.; Namazova-Baranova, L.; Nieto Garcia, A.; Pozo Beltran, C. F.; Ratchataswan, T.; Yever, Rivero title: Childhood asthma outcomes during the COVID-19 pandemic: Findings from the PeARL multi-national cohort. date: 2020-10-28 journal: nan DOI: 10.1101/2020.10.27.20219436 sha: 79743686560162582c71bd6893e3486d0317c671 doc_id: 742967 cord_uid: akzlp041 Objective: We evaluated the impact of COVID-19 pandemic on childhood asthma outcomes. Design: The PeARL multinational cohort included children with asthma and non-asthmatic controls recruited during the COVID-19 pandemic and compared current disease activity with data available from the previous year. Setting: Pediatric outpatient clinics. Participants: The study included 1,054 children with asthma and 505 non-asthmatic controls, aged between 4-18 years, from 25 pediatric departments, from 15 countries globally. Exposures: COVID-19 pandemic first wave, starting from the date of the first fatality in the respective country. Main outcomes and measures: We assessed the pandemic's impact on the frequency of respiratory infections, emergency presentations and hospital admissions in asthmatic versus non-asthmatic participants, controlling for confounding factors including the pandemic's duration and the frequency of such acute events during 2019. Using paired analyses, we evaluated the impact of the pandemic on the annualized frequency of asthma attacks and the previously mentioned acute events, asthma control, and pulmonary function in children with asthma, compared to their baseline disease activity, during the preceding year. Results: During the pandemic, children with asthma experienced fewer upper respiratory tract infections, episodes of pyrexia, emergency visits, hospital admissions, asthma attacks and hospitalizations due to asthma, in comparison to the preceding year. Sixty-six percent of asthmatic children had improved asthma control while in 33% the improvement exceeded the minimally clinically important difference. Pre-bronchodilatation FEV1 and peak expiratory flow rate were also improved during the pandemic. When compared to non-asthmatic controls, children with asthma were not found to be at increased risk of LRTIs, episodes of pyrexia, emergency visits or hospitalizations during the pandemic. However, an increased risk of URTIs emerged. Conclusions and relevance: Childhood asthma outcomes, including control, were improved during the first wave of the COVID-19 pandemic, probably because of reduced exposure to asthma triggers and increased treatment adherence. The decreased frequency of acute episodes does not support the notion that childhood asthma may be a risk factor for COVID-19. Furthermore, the potential for improving childhood asthma outcomes through environmental control becomes apparent. All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted October 28, 2020. ; G a r c i a , N i k o l a o s G . P a p a d o p o u l o s , W a n d a P h i p a t a n a k u l , P a u l o M C P i t r e z , D a v i d P r i c e , P e t r P o h u n e k , G r a h a m C . R o b e r t s , A z i z S h e i k h , I o a n n a T s i l i g i a n n i , S t e v e T u r n e r , A r u n a s V a l i u l i s , T o n y a W i n d e r s , G a r y W o n g , P a r a s k e v i X e p a p a d a k i , O s m a n M . Y u s u f , H e a t h e r Z a r . A u t h o r c o n t r i b u t i o n : S t u d y c o n c e p t i o n : N G P . S t u d y d e s i g n : N G P . D a t a c o l l e c t i o n : A l l a u t h o r s . D a t a a n a l y s i s : A G M , N G P . I n t e r p r e t a t i o n o f t h e f i n d i n g s : A l l a u t h o r s . C r i t i c a l r e v i s i o n o f t h e m a n u s c r i p t : A l l a u t h o r (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted October 28, 2020. ; c h i l d r e n h a d i m p r o v e d a s t h m a c o n t r o l w h i l e i n 3 3 % t h e i m p r o v e m e n t e x c e e d e d t h e m i n i m a l l y c l i n i c a l l y i m p o r t a n t d i f f e r e n c e . P r e -b r o n c h o d i l a t a t i o n F E V 1 a n d p e a k e x p i r a t o r y f l o w r a t e w e r e a l s o i m p r o v e d d u r i n g t h e p a n d e m All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted October 28, 2020. ; s e r i e s o f s t u d i e s h a v e d e m o n s t r a t e d t h a t t h e m o r b i d i t y f r o m C o r o n a v i r u s D i s e a s e 2 0 1 . . (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted October 28, 2020. ; n o n -a s t h m a t i c c o n t r o l s . W e a i m e d a t a s s e s s i n g a s t h m a a c t i v i t y ( a s t h m a c o n t r o l , r e s p i r a t o r y i n f e c t i o n s , a s t h m a a t t a c k s , l u n g f u n c t i o n ) d u r i n g t h e f i r s t m o n t h s o f t h e C O V I D -1 9 p a n d e m i c a n d e x p l o r i n g w h e t h e r c h i l d r e n w i t h a s t h m a h a d e x c e s s m o r b i d i t y d u r i n g t h i s p e r i o d , i n c o m p a r i s o n t (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted October 28, 2020. ; https://doi.org/10.1101/2020.10.27.20219436 doi: medRxiv preprint j e c t s w e r e c h i l d r e n a g e d b e t w e e n 4 a n d 1 8 y e a r s , d i a g n o s e d w i t h a s t h m a a n d m o n i t o r e d i n o n e o f t h e p a r t i c i p a t i n g a s t h m a c l i n i c s . N o n -a s t h m a t i c c o n t r o l s i n c l u d e d c h i l d r e n o f t h e s a m e a g e r a n g e , m o n i t o r e d a t t h e s a m e h e a l t h c a r e s e t t i n g f o r a n o n -r e s p i r a t o r y c o n d i t (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted October 28, 2020 . d u r i n g a n d b e f o r e t h e p a n d e m i c w a s m e a s u r e d u s i n g v a l i d a t e d d i s e a s e c o n t r o l q u e s t i o n n a i r e s ( a s t h m a c o n t r o l t e s t : A C T 1 8 , c h i l d h o o d a s t h m a c o n t r o l t e s t : C -A C T 1 9 , a s t h m a c o n t r o l q u e s t i o n n a i r e : A C Q 2 0 , o r c o m p o s i t e a s t h m a s e v e r i t y i n d e x : C A S I 2 1 ) (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted October 28, 2020. ; a l l e r g i c r h i n i t i s , I g E s e n s i t i z a t i o n , f o o d a l l e r g y a n d h i s t o r y o f f l u v a c c i n a t i o n d u r i n g t h e p r e c e d i n (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted October 28, 2020. ; https://doi.org/10.1101/2020.10.27.20219436 doi: medRxiv preprint All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted October 28, 2020. ; a s s o c i a t e d w i t h a d e c r e a s e d r i s k o f p y r e x i a ( p = 0 . 0 2 5 ) , w h i l e t h e r a c e o f t h e p a r t i c i p a n t s w a s a l s o a s s o c i a t e d w i t h t h e f r e q u e n c y o f t h e s e e v e n t All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted October 28, 2020. ; i v e n t h e s e a s o n a l d i f f e r e n c e s i n a s t h m a c o n t r o l , w e c o n d u c t e d a s e n s i t i v i t y a n a l y s i s w h e r e w e o n l y i n c l u d e d h i s t o r i c a l a s t h m a c o n t r o l m e a s u r e m e n t s c o n d u c t e d d u r i n g t h e s a m e m o n t h s w i t h t h e f i r s t m o n t h s o f t h e p a n d e m i c ( M a r c h -J u n e 2 0 1 9 ) , w i t h c o n s i s t e n t f i n d i n g s ( t a b l e 4 ) . ) . All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted October 28, 2020. ; I C U a d m i s s i o n 2 9 . H o w e v e r , C O V I D -1 9 i n f e c t i o n w a s s i g n i f i c a n t l y u n d e r d i a g n o s e d d u r i n g t h e i n i t i a l m o n t h s o f t h e p a n d e m i c d u e t o l i m i t e d a v a i l a b i l i t y o f d i a g n o s t i c t e s t s , t h a t l e d m o s t c o u n t r i e s t o r e c o m m e n d h o m e i s o l a t i o n w i t h o u t t e s t i n g i n c a s e o f n o n -s e v e r e s y m p t o m s c o n s i s t e n t w i t h C O V I D -1 c o n t r a r y , a n d i n l i n e w i t h o u r r e s u l t s , t h e i n c i d e n c e o f a c u t e r e s p i r a t o r y t r a c t i n f e c t i o n s a n d a c u t e a s t h m a a t t a c k s d e c l i n e d d r a m a t i c a l l y , l i k e l y d u e t o t h e c l o s u r e o f s c h o o l s f o r a p e r i o d o f t i m e , s t e p p e d -u p p u b l i c h y g i e n e m e a s u r e s a n d t h e u s e o f f a c e m a s k s 3 6 , 3 38, 39 . Analysis of induced sputum samples in a well-characterized cohort of adults with severe asthma found reduced ACE2 (angiotensin-converting enzyme 2) and TMPRSS2 All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted October 28, 2020. ; (transmembrane protease serine 2) gene expression among patients taking ICS, and especially among those on higher doses 40 ; and we know ACE2 and TMPRSS2 mediate SARS-CoV-2 cell infection. Similarly, a recent study done in children and adults showed that patients with asthma and respiratory allergies had reduced ACE2 gene expression in airway cells, suggesting a potential mechanism of reduced COVID-19 risk 11 (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted October 28, 2020. ; h i g h -q u a l i t y s t u d i e s d e m o n s t r a t e a p e a k i n c h i l d h o o d a s t h m a a t t a c k d u r i n g a u t u m n a n d s c h o o l s r e o p e n i n g , w h i c h i s c o u n t e r -b a l a n c e d b y a l o w f r e q u e n c y d u r i n g s u m m e r 4 2 , 4 4 . I n t e r e s t i n g l y , t h e s e s t u d i e s c o n s i s t e n t l y s h o w t h a t t h e f r e q u e n c y o f a s t h m a a t t a c k s a n d a s t h m a h o s p i t a l i z a t i o n s d u r i n g s p r i n g a n d e a r l y s u m m e r l e v e l s w i t h t h e m e d i a n f r e q u e n c y o f a s t h m a a t t a c k s (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted October 28, 2020. ; t h e f r e q u e n c y o f a c u t e e p i s o d e s t h a t c o u l d r e p r e s e n t C O V I D -1 9 i n f e c t i o n , r e f u t i n g t h e h y p o t h e s i s t h a t c h i l d h o o d a s t h m a i s a r i s k f a c t o r f o r C O V I D -1 9 . All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted October 28, 2020. ; r e s p e c t i v e o b s e r v a t i o n p e r i o d . B e t w e e n g r o u p d i f f e r e n c e s a s s e s s e d u s i n g g e n e r a l i z e d l i n e a r m o d e l s . T h e f i r s t m o d e l c o n s i d e r s t h e a g e , g e n d e r a n d h i s t o r i c a l n u m b e r o f a c u t e e v e n t s a s c o v a r i a t e s , w h i l e t h e s e c o n d m o d e l a l s o a c c o u n t s f o r t h e r a c e , p a s s i v e s m o k i n g h i s t o All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted October 28, 2020. ; P u l m o n a r y f u n c t i o n t e s t N M e a n 2 0 1 9 M e a n p a n d e m i c P -v a l All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted October 28, 2020. ; y e a r . All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted October 28, 2020. D ) . Clinical and Immune Features of Hospitalized Pediatric Patients With Coronavirus Disease Characteristics and Outcomes of Children With Coronavirus Disease 2019 (COVID-19) Infection Admitted to US and Canadian Pediatric Intensive Care Units Susceptibility to SARS-CoV-2 Infection Among Children and Adolescents Compared With Adults: A Systematic Review and Meta-analysis Risk Factors for Hospitalization, Mechanical Ventilation, or Death Among 10 131 US Veterans With SARS-CoV-2 Infection Risk Factors Associated With Mortality Among Patients With COVID-19 in Intensive Care Units in Factors associated with COVID-19-related death using OpenSAFELY CDC COVID-19 Response Team. Coronavirus disease 2019 in children-United States Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan COVID-19 rapid guideline: severe asthma. 2020. NICE guideline [NG166 Impact of COVID-19 on pediatric asthma: Practice adjustments and disease burden Association of respiratory allergy, asthma, and expression of the SARS-CoV-2 receptor ACE2 COVID-19 lockdown dropped the rate of paediatric asthma admissions Pediatric Asthma Health Care Utilization, Viral Testing, and Air Pollution Changes During the COVID-19 Asthma and COVID-19 in children: A systematic review and call for data The Unexpected Risks of COVID-19 on Asthma Control in Children Research Priorities in Pediatric Asthma: Results of a Global Survey of Multiple Stakeholder Groups by the Pediatric Asthma in Real Life (PeARL) Think Tank The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies Development of the asthma control test: a survey for assessing asthma control Development and cross-sectional validation of the Childhood Asthma Control Test Identifying 'well-controlled' and 'not wellcontrolled' asthma using the Asthma Control Questionnaire Development and validation of the Composite Asthma Severity Index--an outcome measure for use in children and adolescents Toward personalization of asthma treatment according to trigger factors The need for clean air: the way air pollution and climate change affect allergic rhinitis and asthma Pediatric Asthma Healthcare Utilization, Viral Testing, and Air Pollution Changes during the COVID-19 Pandemic The Indirect Impact of COVID-19 on Children With Asthma ARIA-EAACI statement on asthma and COVID-19 The association between COVID 19 and asthma: a systematic review and meta analysis Asthma and COVID-19: review of evidence on risks and management considerations Does Asthma Increase the Mortality of Patients with COVID-19?: A Systematic Review and Meta-Analysis. Int Arch Allergy Immunol The Relationship Between Real-World Inhaled Corticosteroid Adherence and Asthma Outcomes: A Multilevel Approach Acute asthma management during SARS-CoV2-pandemic 2020 Preventing Severe Asthma Exacerbations in Children. A Randomized Trial of Mite-Impermeable Bedcovers Virus-triggered exacerbation in allergic asthmatic children: neutrophilic airway inflammation and alteration of virus sensors characterize a subgroup of patients Childhood severe acute respiratory syndrome, coronavirus infections and asthma Clinical presentations and outcome of severe acute respiratory syndrome in children Childhood severe acute respiratory syndrome, coronavirus infections and asthma Clinical presentations and outcome of severe acute respiratory syndrome in children Inhibitory effects of glycopyrronium, formoterol, and budesonide on coronavirus HCoV-229E replication and cytokine production by primary cultures of human nasal and tracheal epithelial cells The inhaled corticosteroid ciclesonide blocks coronavirus RNA replication by targeting viral NSP15 National Heart L, Blood Institute Severe Asthma Research Program I. COVID-19 Related Genes in Sputum Cells in Asthma: Relationship to Demographic Features and Corticosteroids Rhinovirus Species-Specific Antibodies Differentially Reflect Clinical Outcomes in Health and Asthma The September epidemic of asthma hospitalization: school children as disease vectors Understanding the seasonal pattern of childhood asthma: Results from the national cooperative inner-city asthma study (NCICAS) Seasonal risk factors for asthma exacerbations among inner-city children A c u t e e v e n t s C h i l d r e n w i t h a s t h m a C o n t r o l s B e t w e e n g r o u p d i f f e r e n c e